We are live on
!
Find out more
CFO
Callan Family Office Portfolio holdings
AUM
$4.41B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$379M
AUM Growth
-$32.8M
(-8%)
Cap. Flow
-$52.7M
Cap. Flow
% of AUM
-13.9%
Top 10 Holdings %
Top 10 Hldgs %
65.17%
Holding
161
New
8
Increased
29
Reduced
62
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$714K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$618K |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$519K |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$426K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.88M |
| 2 |
Microsoft
MSFT
|
+$2.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.36M |
| 4 |
Occidental Petroleum
OXY
|
+$1.6M |
| 5 |
Wells Fargo
WFC
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.84% |
| 2 | Financials | 2.84% |
| 3 | Healthcare | 1.16% |
| 4 | Industrials | 0.99% |
| 5 | Consumer Staples | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Elanco Animal Health
ELAN
$11.1B
| – | – |
-11,500
| Closed | -$108K |
|
127
FedEx
FDX
$75.4B
| – | – |
-5,715
| Closed | -$1.31M |
|
128
Fox Class A
FOXA
$26.9B
| – | – |
-8,000
| Closed | -$272K |
|
129
GE Aerospace
GE
$384B
| – | – |
-11,694
| Closed | -$892K |
|
130
GE HealthCare
GEHC
$32.4B
| – | – |
-4,899
| Closed | -$402K |
|
131
Gilead Sciences
GILD
$165B
| – | – |
-13,778
| Closed | -$1.14M |
|
132
GSK
GSK
$106B
| – | – |
-25,900
| Closed | -$922K |
|
133
W.W. Grainger
GWW
$60.2B
| – | – |
-500
| Closed | -$344K |
|
134
Haleon
HLN
$44.2B
| – | – |
-41,900
| Closed | -$341K |
|
135
iShares Russell 2000 Value ETF
IWN
$14.6B
| – | – |
-2,752
| Closed | -$377K |
|
136
Johnson Controls International
JCI
$92.2B
| – | – |
-17,745
| Closed | -$1.07M |
|
137
Microchip Technology
MCHP
$46B
| – | – |
-14,563
| Closed | -$1.22M |
|
138
Mondelez International
MDLZ
$79.9B
| – | – |
-4,019
| Closed | -$280K |
|
139
Medtronic
MDT
$112B
| – | – |
-5,811
| Closed | -$468K |
|
140
MetLife
MET
$62.1B
| – | – |
-14,542
| Closed | -$843K |
|
|
MRSH
141
Marsh
MRSH
$91.5B
| – | – |
-1,374
| Closed | -$229K |
|
142
Nike
NKE
$61.9B
| – | – |
-2,134
| Closed | -$262K |
|
143
Novartis
NVS
$297B
| – | – |
-9,605
| Closed | -$884K |
|
|
144
Occidental Petroleum
OXY
$55.9B
| – | – |
-25,651
| Closed | -$1.6M |
|
145
Regeneron Pharmaceuticals
REGN
$80.8B
| – | – |
-786
| Closed | -$646K |
|
146
ResMed
RMD
$30.7B
| – | – |
-1,034
| Closed | -$226K |
|
147
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$303M
| – | – |
-4,189
| Closed | -$380K |
|
148
Starbucks
SBUX
$120B
| – | – |
-2,051
| Closed | -$214K |
|
149
Sanofi
SNY
$104B
| – | – |
-24,800
| Closed | -$1.35M |
|
150
S&P Global
SPGI
$120B
| – | – |
-708
| Closed | -$244K |
|
Similar funds
FIS
CAU
EQF
SFM
EC
IC
GIBU
Callan Family Office's Q2 2023 Portfolio in Review
As of Q2 2023, Callan Family Office held 161 positions worth $379M, down 8% from $412M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Callan Family Office withdrew a net $52.7M in Q2 2023, closing 51 positions and reducing 62 holdings. Its most notable exit was Occidental Petroleum, an estimated $1.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 5.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Callan Family Office opened a new position in Vanguard Morningstar Small-Cap ETF worth $231K.
- Callan Family Office's largest Q2 2023 buy was Vanguard Morningstar Small-Cap ETF: 1,159 shares worth $231K.
- Callan Family Office added most to iShares Core MSCI EAFE ETF in Q2 2023, an estimated $1M increase.
- Callan Family Office's biggest Q2 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $2.88M.
- Callan Family Office fully exited Occidental Petroleum in Q2 2023, selling an estimated $1.6M.
- Callan Family Office's ten largest holdings make up 65% of its $379M portfolio in Q2 2023.
- Callan Family Office opened 8 new positions and closed 51 in Q2 2023.
- Callan Family Office's portfolio value fell 8% quarter-over-quarter to $379M.
Based on Callan Family Office's 13F filing for Q2 2023, filed 14 Aug 2023.